STOCK TITAN

AMBEV S.A. (ABEV) SEC Filings

ABEV NYSE

Ambev S.A. filings document the reporting cycle of a Brazilian foreign private issuer with NYSE ADRs and B3-listed common shares. Form 20-F reports cover audited financial statements and annual business disclosure, while Form 6-K submissions furnish interim consolidated financial statements, quarterly operating results and current reports under Exchange Act rules for foreign issuers.

The filing record also covers beverage segment performance in Brazil Beer, Brazil NAB, Latin America South, Central America and the Caribbean, and Canada; capital allocation through interest on capital; treasury share activity; management and related-person securities transactions under Brazilian CVM rules; shareholder-meeting voting maps; board resolutions; committee matters; compensation; and other governance disclosures.

Rhea-AI Summary

AMBEV S.A. reported treasury common-share transactions for October 2026. Its initial treasury balance was 68,178,365 common shares and its final balance was 70,649,693 common shares. On October 2, 2026, 63,172 restricted shares were delivered directly with the company; the table lists a price of R$15.42000 and volume of R$974,112.24. Through Corretora Santander, the table lists a purchase of 2,500,000 common shares on October 29, 2026, at R$14.66399, with a volume of R$36,659,975.00, and a purchase of 34,500 shares on October 30, 2026, at R$14.40000, with a volume of R$496,800.00. The initial and final ADR quantities were each 0.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
current report
-
Rhea-AI Summary

AMBEV S.A. reported October 2026 management securities-lending activity involving 874 common shares in each lending transaction. The first lending transaction was reported on October 1 and its return on October 5, both at a listed price of 15.36000 per share; another lending transaction was reported on October 6 and its return on October 14, both at 16.50000 per share. Management’s initial and final balances were 3,027,710 common shares and 0 ADRs. The board group’s common-share balance was 30,679,627, and the Fiscal Council group’s was 2,500, in both their initial and final balances.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
current report
-
Form 6-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.96%
Tags
current report
Rhea-AI Summary

AMBEV S.A. approved a share buyback program for up to 190,000,000 common shares, with cancellation as its primary purpose. The program will be in effect until April 28, 2028, and purchases may be made within up to 18 months from approval. Shares not canceled may be held in treasury, transferred, or used for share-based compensation plans.

The company estimates that repurchasing all 190,000,000 shares would cost approximately R$ 2.9 billion, based on the closing share price on October 28, 2026. It says this would represent approximately 15% of cash and cash equivalents in its most recent financial statements. The acquisition will be recorded as a debit to the capital reserve account in the balance sheet dated September 30, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.96%
Tags
current report
-
Rhea-AI Summary

AMBEV S.A. approved a share buyback program of up to 190,000,000 common shares, primarily for cancellation, at a Board meeting on October 28, 2026. Any remaining shares may be held in treasury, transferred, and/or delivered under the Company’s share-based compensation plans. The program remains in effect until April 28, 2028. The acquisition will be recorded as a debit on the capital reserve in the balance sheet dated as of September 30, 2026. Transactions will be carried out through Santander Institucional Corretora de Câmbio e Valores Mobiliários S.A., Ágora Corretora de Títulos e Valores Mobiliários S.A., and Goldman Sachs do Brasil Corretora de Títulos e Valores Mobiliários S.A.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.96%
Tags
current report
-
Rhea-AI Summary

Ambev S.A. (ABEV) reported third-quarter 2026 net revenue of R$21.5946 billion, up 7.6% organically, while normalized EBITDA was R$7.2709 billion, up 8.9% organically. Normalized EBITDA margin was 33.7%, 40 basis points higher organically. Consolidated volume increased 0.8%, and net revenue grew in all business units. Cash flow from operating activities was R$7.6779 billion, up 11.0% from R$6.9190 billion in 3Q25.

Normalized profit rose 14.3% to R$4.3936 billion, while reported profit fell 10.2% to R$4.3663 billion. Ambev’s Board approved a buyback of up to 190,000,000 common shares, corresponding to R$2.9 billion based on the October 28, 2026 closing share price, primarily for cancellation. The program will remain in effect until April 28, 2028; remaining shares may be held in treasury, transferred, or delivered under share-based payment plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.96%
Tags
current report
Rhea-AI Summary

AMBEV S.A. reported net sales of R$64.208 billion and net income of R$11.727 billion for the nine months ended September 30, 2026, compared with R$63.435 billion and R$11.459 billion, respectively, in 2025. Third-quarter net income was R$4.366 billion, versus R$4.864 billion a year earlier. Nine-month cash flow from operating activities was R$15.550 billion, compared with R$11.198 billion.

Ambev completed its buyback program in August, acquiring 208,000,000 common shares for R$3.333 billion. The board approved cancellation of 279,000,000 treasury common shares without reducing share capital. Subsidiary CND completed the third tranche of its SLU sale to Koscab, transferring an additional 12.76% of its interest; 74.48% had been transferred by September 30, 2026, for an accumulated US$139 million, equivalent to R$720 million. The board approved July interest on capital of R$0.0713 gross per share, approximately R$1.1 billion in aggregate, payable by December 31, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.96%
Tags
current report
-
Rhea-AI Summary

AMBEV S.A. will replace Banco Bradesco S.A. with Itaú Unibanco S.A. as the financial institution acting as depositary for its book-entry shares, effective November 23, 2026. Services provided by Bradesco will be suspended from November 12 through November 19, 2026 during the migration. Trading will not be interrupted, and the change will not affect shareholder rights or the bank accounts designated for payments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
current report
-
Rhea-AI Summary

AMBEV S.A. ratified Fernando Maffessoni’s appointment as Vice President of Logistics, effective September 1, 2026. The Board of Directors approved the appointment on May 15, 2026, and approved its effective date at a meeting on July 29, 2026. The composition of the Board of Executive Officers was consolidated with a unified term of office through December 31, 2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
current report
Rhea-AI Summary

AMBEV S.A. reported common-share transactions in its management group during September 2026. The listed transactions include three sales on September 3: 60,700 shares at R$15.76000, 2 shares at R$15.75000, and 55 shares at R$15; it also lists the return of 874 securities lent on September 8 at R$15.31000. The group’s common-share balance was 3,087,593 initially and 3,027,710 at month-end. Board and Fiscal Council balances were unchanged at 30,679,627 and 2,500 shares, respectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.25%
Tags
current report

FAQ

How many AMBEV S.A. (ABEV) SEC filings are available on StockTitan?

StockTitan tracks 143 SEC filings for AMBEV S.A. (ABEV), including 20-F annual reports and 6-K reports. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for AMBEV S.A. (ABEV)?

The most recent SEC filing for AMBEV S.A. (ABEV) was filed on November 10, 2026.